Ketim Technologies, Brisbane (2026)

02/07/2025

What if we could detect perinatal depression before symptoms appear?
Imagine knowing, early in your pregnancy, whether you’re at risk, and getting support sooner. A simple blood test could transform the journey for both parents and babies.

Predicting Perinatal Depression
Perinatal depression is complex and presents differently for everyone. Without clear biological signs, many parents don’t get the help they need until symptoms have already become overwhelming.

Early Detection Methods
Current screening relies on how we’re feeling or what we share with our healthcare team. But often, those who need the help the most are missed. A biological test could spot risks early, long before symptoms appear.

Personalising PPD Treatment
Finding the right help can really feel like trial and error. Biomarker research could change this, helping parents get tailored support sooner — and easing the path to recovery.

💖 Follow us for more insights on how science is reshaping maternal mental health.

19/03/2025

We are starting with perinatal mental health.

At the forefront of scientific discovery, our biotech company pioneers breakthroughs that redefine possibilities in mental health. By harnessing cutting-edge technology and AI, we are committed to transforming lives and shaping a better future for families and generations to come.

Our Why
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can aid in objectively diagnosing patients and providing individualised treatment recommendations.

Integration of biomarkers, clinical data and full patient history for each individual is compounded - this leads to subjective biases and a high rate of under- and mis-diagnoses in mental health.

Our Solution
Ketim Therapeutics is focused on changing the paradigm of psychiatric-care, by building and easing access to big data and molecular biomarkers through a curated database to impact better and faster treatments.

We invite you to join us on this journey.

27/08/2024

🌟 Embracing my passion for mental health care during the perinatal period has been an eye-opening and heartfelt journey for me on many personal levels.

🌼 My transition from pregnancy to early parenthood was overwhelming, and I lacked the emotional and mental well-being during this time. I struggled immensely and was so afraid to reveal it to my Mum friends who all looked like they were nailing it while I felt embarrassed and saddened that I was not coping.

🧠 After seeing my GP and seeing a psychologist, I was diagnosed with postpartum depression (PPD). I was fortunate that antidepressants worked for me from the start and I recovered from this debilitating time. Since then, I have been a passionate advocate for PPD, sharing my own personal story back in 2017 on Channel 9 News for Perinatal Anxiety & Depression Australia (PANDA).

🩸I've had the privilege of connecting with many incredible individuals who have helped me Therapeutics from compassionate healthcare professionals to dedicated advocates, to one day be able to develop a blood-based biomarker screening test for PPD.

♥️ To every new parent out there, you're not alone. We're here to walk this journey with you, prioritising your mental health and well-being every step of the way. 💖

21/07/2024

I am beyond excited to get my new logo - I had one done up earlier in the year using an AI website that helps design logos but over time my lawyer and I discussed thinking of seriously getting one unique to Ketim and ensuring we can apply for a trademark on it with no issues.

So off I went to get it redesigned with a graphic designer - I am so happy with how it turned out. I wanted to keep the four leaf design as my vision for Ketim as the four pillars that will build the foundation of Ketim Therapeutics.

1 - : I hope to discover as many biomarkers as possible for mental disorder using a and to help with the predictive power of the biomarkers.

2- : I hope to define our services and research using engagement with lived experience of the community, ensuring the products I make is fit for clinic and not just research for the sake of research.

3 - : I want to develop products and/or services that will complement the current mental health care in Australia. Whether this be an actual kit or integration into digital platforms, I want to start with Queensland before moving on to national and international communities.

4 - : I hope to deliver to the that need it the most. Perinatal depression doesn't just affect mothers, it also affects infants long-term neurodevelopment, dads/partners, communities and more. First Nations people and +, are impacted even more with perinatal mental illness. I hope to deliver to those who needs it the most.

This model is based of the co-design model developed by by the Design Council (link in comments) which I used in my Strategy and in my grant writing process for developing co-design models for research.

If you want to join me or support me, feel free to follow me over Ketim Therapeutics or visit www.ketim.com.au.

11/03/2024

Never thought this day would come but I got a letter of support as a PRINCIPAL INVESTIGATOR (PI) to conduct perinatal and postpartum depression biomarker research with Mater Research and Ketim Therapeutics. Took about a year in the making but Ketim is now officially in business. Now onto investment funding and grant applications - if you know anyone in the mental health space who might want to collaborate or work with us, feel free to tag me.

Leaving academia to pursue my own independent research has been my dream

Address

Brisbane

4075

Telephone

+61450536373

Website

http://www.ketim.com.au/

Alerts

Be the first to know and let us send you an email when Ketim Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Ketim Technologies:

Ketim Technologies